[
    "{\"step_by_step_thinking\": \"Tremelimumab is a monoclonal antibody that targets the protein CTLA-4, which is involved in the regulation of the immune system. It has been studied as a potential treatment for mesothelioma, a type of cancer that affects the lining of the lungs and abdomen. However, in clinical trials, tremelimumab has not been shown to significantly improve overall survival in patients with mesothelioma.\", \"answer_choice\": \"B. no\"}"
]